| Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study Z Vokó, Z Kiss, G Surján, O Surján, Z Barcza, B Pályi, E Formanek-Balku, ... Clinical Microbiology and Infection 28 (3), 398-404, 2022 | 138 | 2022 |
| Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings DJ Magliano, L Chen, RM Islam, B Carstensen, EW Gregg, ME Pavkov, ... The lancet Diabetes & endocrinology 9 (4), 203-211, 2021 | 125 | 2021 |
| Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data DJ Magliano, L Chen, B Carstensen, EW Gregg, ME Pavkov, A Salim, ... The lancet Diabetes & endocrinology 10 (2), 112-119, 2022 | 47 | 2022 |
| Different trends in excess mortality in a central European country compared to main European regions in the year of the COVID-19 pandemic (2020): a Hungarian analysis K Bogos, Z Kiss, A Kerpel Fronius, G Temesi, E Jenő, I Madurka, Z Cselkó, ... Pathology and Oncology Research 27, 1609774, 2021 | 43 | 2021 |
| Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus G Jermendy, I Wittmann, L Nagy, Z Kiss, G Rokszin, Z Abonyi-Tóth, ... Medical science monitor: international medical journal of experimental and …, 2012 | 40 | 2012 |
| Revising incidence and mortality of lung cancer in Central Europe: an epidemiology review from Hungary K Bogos, Z Kiss, G Gálffy, L Tamási, G Ostoros, V Müller, L Urbán, ... Frontiers in oncology 9, 1051, 2019 | 38 | 2019 |
| Effectiveness and waning of protection with different SARS-CoV-2 primary and booster vaccines during the Delta pandemic wave in 2021 in Hungary (HUN-VE 3 Study) Z Vokó, Z Kiss, G Surján, O Surján, Z Barcza, I Wittmann, GA Molnár, ... Frontiers in immunology 13, 919408, 2022 | 37 | 2022 |
| Nationwide effectiveness of first and second SARS-CoV2 booster vaccines during the delta and omicron pandemic waves in Hungary (HUN-VE 2 study) Z Kiss, I Wittmann, L Polivka, G Surján, O Surján, Z Barcza, GA Molnár, ... Frontiers in Immunology 13, 905585, 2022 | 34 | 2022 |
| Persistence with statin therapy in Hungary Z Kiss, L Nagy, I Reiber, G Paragh, MP Molnar, G Rokszin, Z Abonyi-Toth, ... Archives of Medical Science 9 (3), 409-417, 2013 | 30 | 2013 |
| Changes in the incidence and prevalence of type 1 and type 2 diabetes among 2 million children and adolescents in Hungary between 2001 and 2016–a nationwide population-based study L Barkai, Z Kiss, G Rokszin, Z Abonyi-Tóth, G Jermendy, I Wittmann, ... Archives of medical science 16 (1), 34-41, 2020 | 28 | 2020 |
| Persistence to treatment with novel antidiabetic drugs (dipeptidyl peptidase-4 inhibitors, sodium-glucose co-transporter-2 inhibitors, and glucagon-like peptide-1 receptor … G Jermendy, Z Kiss, G Rokszin, Z Abonyi-Tóth, I Wittmann, P Kempler Diabetes Therapy 9, 2133-2141, 2018 | 26 | 2018 |
| Changing trends in melanoma incidence and decreasing melanoma mortality in Hungary between 2011 and 2019: a nationwide epidemiological study G Liszkay, Z Kiss, R Gyulai, J Oláh, P Holló, G Emri, A Csejtei, I Kenessey, ... Frontiers in oncology 10, 612459, 2021 | 19 | 2021 |
| A 2-es típusú diabetes előfordulása és költségterheinek alakulása Magyarországon 2001–2014 között–az Országos Egészségbiztosítási Pénztár adatbázis-elemzésének eredményei P Kempler, P Zs, Z Kiss, I Wittmann, AT Zs, R Gy, J Gy Diabetologia Hungarica 24 (3), 177-188, 2016 | 19 | 2016 |
| Age and gender specific lung cancer incidence and mortality in Hungary: trends from 2011 through 2016 L Tamási, K Horvath, Z Kiss, K Bogos, G Ostoros, V Müller, L Urbán, ... Pathology and Oncology Research 27, 598862, 2021 | 18 | 2021 |
| Decreasing incidence of pharmacologically treated Type 2 diabetes in Hungary from 2001 to 2016: A nationwide cohort study G Jermendy, Z Kiss, G Rokszin, Z Abonyi-Toth, I Wittmann, P Kempler diabetes research and clinical practice 155, 107788, 2019 | 18 | 2019 |
| Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary Z Kiss, G Rokszin, Z Abonyi-Tóth, G Jermendy, P Kempler, D Aradi, ... Cardiovascular Diabetology 17, 1-8, 2018 | 18 | 2018 |
| Lung cancer in Hungary K Bogos, Z Kiss, G Gálffy, L Tamási, G Ostoros, V Müller, L Urbán, ... Journal of Thoracic Oncology 15 (5), 692-699, 2020 | 17 | 2020 |
| Prevalence and financial burden of type 2 diabetes mellitus in Hungary between 2001–2014—results of the analysis of the National Health Insurance Fund database P Kempler, Z Putz, Z Kiss, I Wittmann, Z Abonyi-Tóth, G Rokszin, ... Diab Hung 24 (3), 177-88, 2016 | 16 | 2016 |
| How can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia … L Mark, G Paragh, I Karadi, I Reiber, G Pados, Z Kiss Archives of Medical Science 8 (4), 608-613, 2012 | 16 | 2012 |
| Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study G Sütő, GA Molnár, G Rokszin, I Fábián, Z Kiss, Z Szekanecz, G Poór, ... BMJ Open Diabetes Research and Care 9 (1), e001765, 2021 | 15 | 2021 |
